Tamoxifen inhibits arylamine N-acetyltransferase activity and DNA-2-aminofluorene adduct in human leukemia HL-60 cells

Research Communications in Molecular Pathology and Pharmacology

Volumn 109, Issue 5-6, 2001, Pages 319-331

  Lu, Ko Hsiu ^a   Lin, Keh Liang ^a   Hsia, Te Chun ^b   Hung, Chi Fu ^c   Chou, Ming Chih ^a   Hsiao, Yie Ming ^a   Chung, Jing Gung ^d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c JEN AI HOSPITAL   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

2 aminofluorene; Human leukemia cells; N acetyl 2 aminofluorene; N acetyltransferase (NAT); Tamoxifen

Indexed keywords

2 FLUORENYLAMINE; ACETYL COENZYME A ACETYLTRANSFERASE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; O ACETYLTRANSFERASE; TAMOXIFEN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOSOL; DNA ADDUCT; DOSE RESPONSE; DRUG INHIBITION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC REGULATION; HUMAN; HUMAN CELL; METABOLIC ACTIVATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STEADY STATE;

2-ACETYLAMINOFLUORENE; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HL-60 CELLS; HUMANS; TAMOXIFEN;

EID: 0041307168     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Blum, M., Grant, D. M., McBride, W., Heim M. and Myere, U. A. (1990). Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol. 9: 193-203.
2. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
3. Campbell, D. A., Schoenwald R. D., Duffel M. W. and Barknecht C. F. (1991). Characterization of arylamine acetyltransferase in the rabbit eye. Invest. Opththamol. Vis. Sci. 32: 2190-2200.
4. Chung, J. G., Levy G. N. and Weber W. W. (1993). Distribution of 2-aminofluorene and p-aminobenzoic acid N-acetyltransferase activity in tissues of C57BL/6J rapid and B6.A-Nats slow acetylator leukemia. DrugMeta. Dispos. 21: 1057-1063.
5. Chung, J. G., Chang H. L., Lin W. C., Wang H. H., Yeh C. C., Hung C. F. and Li Y. C. (2000). Inhibitory of N-acetyltransferase activity and DNA-2-aminofluorene adducts by glycyrrhizic acid in human colon tumour cells. Food and Chem. Toxicol. 38: 163-172.
6. Clayson, D. B. and Gamer R. C. (1976). Carcinogenic aromatic amines and related compounds. In Chemical Carcinogens (C. E. Searle, Ed.), Monograph 173, pp. 366-461. American Chemical Society, Washington, DC.
7. Cleland, W. W. (1967). The statistical analysis of enzyme kinetic data. Adv. Enzymol. 29: 1-14.
8. Cruz Silca, M. M., Madeira V. M.C., Almeida L. M. and Custodio J. B. A. (2000). Hemolysis of human erythrocytes induced by tamoxifen is related to disruption of membrane structure. Biochimica et Biophysica Acta. 1464: 49-61.
9. Das, R. and Vonderhaar B. K. (1997). Tamoxifen inhibits prolactin signal transduction in ER-NOG-S mammary epithelial cells. Cancer Lett. 11: 41-46.
10. Ebisawa, T. and Deguchi T. (1991). Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferase. Biochem. Biophys. Res Commun. 177: 1252-1257.
11. Einisto, P., Watanabe M., Ishidate M. and Nohmi T. (1991). Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res. 259: 95-102.
12. Grant, D. M., Blum M., Beer M. and Meyer U.A. (1991). Monomorphic and polymorphic human arylamine N-acetyltransferase: A comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol. 39: 184-191.
13. Minchin, R. P., Reeves P. T., Teitel C. H., McManus M. E., Mojarrabi T., Ilett K. F. and Kadlubar F. F. (1992). N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem. Biophys. Res. Commun. 185: 839-844.
14. Guvakova, M. A. and Surmacz E. (1997). Tamoxifen interferes with the insulin-like growth factor I receptor (IGF-IR) signaling pathway in breast cancer cells. Cancer Res. 57: 2606-2610.
15. Hein, D. W. (1988). Acetylator genotype and arylamine-induced carcinogenesis. Biochim. Biophys. Acta. 948: 37-66.
16. Hsia, T. C., Hung C. F., Lu H. F., Ho H. C., Lu K. H. and Chung J. G. (2001). Paclitaxel inhibited the 2-aminofluorene-DNA adducts formation and arylamine N-acetyltransferase activity and gene expression in human lung tumor cells (A549). Food and Chemical Toxicol. (in press), 2001.
17. 2+ and cytotoxicity in intact cells. Toxicol. Applied Pharmacol. 168: 58-63.
18. Jordan, V. C. (1990). Long-Term adjuvant tamoxifen therapy for breast cancer. Breast Cancer Res. Treat. 15: 125-136.
19. Kanter-Lewensolin L., Gimita L., Gimita A., Dricu A., Olsson G., Leech L., Nilsson G., Hilding A., Wejde J., Brismar K. and Larsson O. (2000) Tamoxifen-induced cell death in malignant melanoma cells: possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. Mol. Cellul. Endocrinol. 165: 131-137.
20. King, C. M., Romano L. J. and Schuetzle D. (1988). Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes. Elsevier, New York.
21. Lee, J. H., Chung J. G., Lai J. M., Levy G. N. and Weber W. W. (1997). Kinetics of arylamine N-acetyltransferase in tissues from human breast cancer. Cancer Lett. 111: 39-50.
22. Levy, G. N. and Weber W. W. (1992). 2-Aminofluorene-DNA adducts in mouse urinary bladder: Effect of age, sex, and acetylator phenotype. Carcinogenesis 13: 159-164.
23. Mcqueen, C. A., Maslansky C. J., Glowinski I.B., Crescenzi S. B., Weber W. W. and illiams G. M. (1982). Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes. Proc. Natl. Acad. Sci. USA. 79: 1269-1272.
24. Ponte, P., Ng S. Y., Engel J., Gunning P. and Kedes, L. (1984). Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 12: 1687-1696.
25. Shy, H., Malaiyandi L. and Timiras P. S. (2000). Protective action of 17 β-estradiol and tamoxifen on glutamate toxicity in glial cells. Int. J. Devl Neuroscience. 18: 289-297.
26. Smith, G., Stanley L. A., Sim E., Strange R. C. and Wolf, C. R. (1995). Metabolic polymorphisms and cancer susceptibility. Cancer Surv. 25: 27-65.
27. Thorgeirsson, S. S., Glowinski I. B. and McManus M. E. (1983). Metabolism, mutagenicity, carcinogenicity of aromatic amines, in: J. Hodgson, J. Bend and R. M. Philpot (Eds.,), Reviews in Biochemical Toxicity, Vol. 6, Elsevier/North Holland Biomedical Press, New York, pp.349-386.
28. Weber, W. W. and Hein D.W. (1985). N-acetylation pharmacogenetics. Pharmacol. Rev. 37: 25-99.